Senté, Inc. raised $2.1 million from a combination of new and existing biotechnology investors

Senté, Inc. announces that it has closed its Series-B financing, raising $2.1 million from a combination of new and existing biotechnology investors. Proceeds from the financing will help Senté, Inc. expand commercial operations, scale development capabilities, and add additional line extensions to its portfolio of differentiated medical grade skin care products.
Login to post comments

Inside Aesthetics Categories

    Featured Company

    • Celluma by Biophotas, IncCelluma by Biophotas, IncDescription: No matter the age, we all strive to be healthy, pain free and to look and feel our very best. The Celluma from BioPhotas, Inc. is a specialized light emitting diode (LED) device designed to treat arthritis, muscle spasm, muscle and joint pain, muscle ti ...

    Inside Aesthetics

    Next-Level Learning

    • Southeastern EstheticsSoutheastern EstheticsDescription: Welcome to Southeastern Esthetics Institute, a premier esthetics training institute located in the heart of South Carolina. SEEI is more than just an esthetics training program, we are a one of a kind esthetics school that offers an intimate setting and ...